Zai Lab Statistics
Total Valuation
Zai Lab has a market cap or net worth of $2.19 billion. The enterprise value is $1.72 billion.
Important Dates
The last earnings date was Thursday, February 26, 2026, before market open.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Zai Lab has 112.07 million shares outstanding. The number of shares has increased by 10.70% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 112.07M |
| Shares Change (YoY) | +10.70% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 1.73% |
| Owned by Institutions (%) | 53.77% |
| Float | 103.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.76 |
| Forward PS | 9.15 |
| PB Ratio | 3.02 |
| P/TBV Ratio | 3.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.31.
| Current Ratio | 2.45 |
| Quick Ratio | 1.94 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -44.05 |
Financial Efficiency
Return on equity (ROE) is -22.56% and return on invested capital (ROIC) is -14.83%.
| Return on Equity (ROE) | -22.56% |
| Return on Assets (ROA) | -12.16% |
| Return on Invested Capital (ROIC) | -14.83% |
| Return on Capital Employed (ROCE) | -30.34% |
| Weighted Average Cost of Capital (WACC) | 8.43% |
| Revenue Per Employee | $246,204 |
| Profits Per Employee | -$93,920 |
| Employee Count | 1,869 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 7.19 |
Taxes
| Income Tax | -2.93M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.59% in the last 52 weeks. The beta is 0.88, so Zai Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | -45.59% |
| 50-Day Moving Average | 18.48 |
| 200-Day Moving Average | 27.56 |
| Relative Strength Index (RSI) | 55.12 |
| Average Volume (20 Days) | 631,135 |
Short Selling Information
| Short Interest | 3.37M |
| Short Previous Month | 3.59M |
| Short % of Shares Out | 3.41% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.34 |
Income Statement
In the last 12 months, Zai Lab had revenue of $460.16 million and -$175.54 million in losses. Loss per share was -$1.60.
| Revenue | 460.16M |
| Gross Profit | 48.17M |
| Operating Income | -229.43M |
| Pretax Income | -178.46M |
| Net Income | -175.54M |
| EBITDA | -214.42M |
| EBIT | -229.43M |
| Loss Per Share | -$1.60 |
Full Income StatementBalance Sheet
The company has $689.57 million in cash and $224.26 million in debt, with a net cash position of $465.31 million or $4.15 per share.
| Cash & Cash Equivalents | 689.57M |
| Total Debt | 224.26M |
| Net Cash | 465.31M |
| Net Cash Per Share | $4.15 |
| Equity (Book Value) | 715.50M |
| Book Value Per Share | 6.47 |
| Working Capital | 603.12M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$150.79 million and capital expenditures -$8.10 million, giving a free cash flow of -$158.89 million.
| Operating Cash Flow | -150.79M |
| Capital Expenditures | -8.10M |
| Free Cash Flow | -158.89M |
| FCF Per Share | -$1.42 |
Full Cash Flow StatementMargins
Gross margin is 10.47%, with operating and profit margins of -49.86% and -38.15%.
| Gross Margin | 10.47% |
| Operating Margin | -49.86% |
| Pretax Margin | -38.78% |
| Profit Margin | -38.15% |
| EBITDA Margin | -46.60% |
| EBIT Margin | -49.86% |
| FCF Margin | n/a |
Dividends & Yields
Zai Lab does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.70% |
| Shareholder Yield | -10.70% |
| Earnings Yield | -8.02% |
| FCF Yield | -7.26% |
Analyst Forecast
The average price target for Zai Lab is $49.44, which is 153.02% higher than the current price. The consensus rating is "Buy".
| Price Target | $49.44 |
| Price Target Difference | 153.02% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 26.73% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Zai Lab has an Altman Z-Score of 1.61 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.61 |
| Piotroski F-Score | 3 |
